Quinapril inhibits c-Myc expression and normalizes smooth muscle cell proliferation in spontaneously hypertensive rats

American Journal of Hypertension

Volumn 10, Issue 10 I, 1997, Pages 1147-1152

  Díez, Javier ^a,b   Panizo, Angel ^b   Hernández, Marta ^a   Galindo, María F ^c   Cenarruzabeitia, Edurne ^c   Pardo Mindán, Francico Javier ^b  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

c Myc; Cyclin A; Intramyocardial arteries; Spontaneously hypertensive rats

Indexed keywords

CYCLIN A; CYCLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ONCOPROTEIN; QUINAPRIL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; IMMUNOCYTOCHEMISTRY; MALE; MORPHOMETRICS; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CELL DIVISION; CYCLIN A; HYPERTENSION; ISOQUINOLINES; MALE; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RATS, INBRED SHR; RATS, INBRED WKY; TETRAHYDROISOQUINOLINES;

EID: 0342710364     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00210-0     Document Type: Article

References (37)

1. Mulvany MJ, Aalkjaer C: Structure and function of small arteries. Physiol Rev 1990;70:921-969.
2. Heagerty A, Aalkjaer C, Bund SJ, et al: Small artery structure in hypertension. Dual process of remodeling and growth. Hypertension 1993;21:391-397.
3. Owens GK, Schwartz SM: Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy and hyperplasia. Circ Res 1982;51:280-289.
4. Amann K, Gharehbaghi H, Stephan S, Mall G: Hypertrophy and hyperplasia of smooth muscle cells of small intramyocardial arteries in spontaneously hypertensive rats. Hypertension 1995;25:124-131.
5. Owens GK: Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am J Physiol 1989;257:H1755-H1765.
6. Simon G, Cserep G, Limas C: Development of structural vascular changes with subpressor angiotensin II administration in rats. Am J Hypertens 1995;8:67-73.
7. Paquet JL, Baudoin-Legros M, Brunelle, Meyer P: Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens 1990;8: 565-572.
8. Morishita R, Gibbons GH, Ellison KE, et al: Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J Clin Invest 1994;94:978-984.
9. Naftilan AJ, Pratt RE, Dzau VJ: Induction of platelet-derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1419-1424.
10. Christensen KL, Jespersen LT, Mulvany MJ: Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens 1989;7:83-90.
11. Panizo A, Pardo J, Hernández M, et al: Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens 1995;8:815-822.
12. Panizo A, Pardo Mindán FJ, Galindo MF, et al: Are mast cells involved in hypertensive heart disease? J Hypertens 1995;13:1201-1208.
13. Lovenberg W: Techniques for the measurement of blood pressure. Hypertension 1987;9(suppl I):I-5-I-6.
14. Gown AM, Vogel AM: Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal tissues. Am J Pathol 1984; 114:309-321.
15. Sherr CJ: Mammalian G1 cyclins. Cell 1993;73:1059-1065.
16. Solomon MJ: Activation of the various cyclin/cdc2 protein kinases. Curr Opin Cell Biol 1993;5:180-186.
17. Gordon D, Reidy MA, Benditt EP, Schwartz SM: Cell proliferation in human coronary arteries. Proc Natl Acad Sei USA 1990;87:4600-4604.
18. Cheung HS, Cushman DW: Inhibition of homogeneous angiotensin converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jaracaca. Biochim Biophys Acta 1973;293:451-463.
19. Cushman DW, Cheung HS: Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 1971;20:1637-1648.
20. Kindy MS, Soneshein GE: Regulation of oncogene expression in cultured aortic smooth muscle cells: post-transcriptional control of c-myc mRNA. J Biol Chem 1986;261:12865-12868.
21. Gadeau AP, Campan M, Desgranges C: Induction of cell cycle-dependent genes during cell cycle progression of arterial smooth muscle cells in culture. J Cell Physiol 1991;146:356-361.
22. Miano JM, Tota RR, Vlasic N, et al: Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal. Am J Pathol 1990;137:761-765.
23. Bauters C, de Groote P, Adamantidis M, et al: Protooncogene expression in rabbit aorta after wall injury: first marker of the cellular process leading to restenosis after angioplasty? Eur Heart J 1992;13:556-559.
24. Bennet MR, Anglin S, McEwan JR, et al: Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest 1994;93:820-828.
25. Edelman ER, Simons M, Sirois MG, Rosenberg RD: c-myc in vasculoproliferative disease. Circ Res 1995;76: 176-182.
26. Morishita R, Gibbons GH, Ellison KE: Single intraluminal delivery of antisense CDC2 kinase and PCNA oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA 1993;90:8474-8478.
27. Brilla CG, Janicki JS, Weber KT: Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991;83:1771-1779.
28. Yamori Y, Igawa T, Kanbe T, et al: Mechanisms of structural vascular changes in genetic hypertension: analysis on cultured vascular smooth muscle cells from spontaneously hypertensive rats. Clin Sci 1981; 61(suppl):121S-123S.
29. Hadrava V, Tremblay J, Hamet P: Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension 1989; 13:589-597.
30. Hamada M, Harris EL, Millar JA, Simpson FO: Temporal differences in the cell cycles of cultured vascular smooth muscle cells from spontaneously hypertensive and normotensive Wistar-Kyoto rats. J Vasc Med Biol 1990;2:136-141.
31. Sudhir K, Wilson E, Chatterjee K, Ives HE: Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells. J Clin Invest 1993;92:3003-3007.
32. Saouaf R, Takasaki I, Eastman E, et al: Fibronectin biosynthesis in the rat aorta in vitro. Changes due to experimental hypertension. J Clin Invest 1991;88:1182-1189.
33. Bashey RI, Cox R, McCann J, Jimenez SA: Changes in collagen biosynthesis, types, and mechanics of aorta in hypertensive rats. J Lab Clin Med 1989;113:604-611.
34. Safar ME, Peronneau PA, Levenson JA, et al: Pulsed Doppler: diameter, blood flow velocity, and volumic flow of the brachial artery in sustained essential hypertension. Circulation 1981;63:393-400.
35. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-1777.
36. Farhy RD, Carretero OA, Ho KL, Scili AG: Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res 1993;72:1202-1210.
37. Himeno H, Crawford DC, Hosoi M, et al: Angiotensin II alters aortic fibronectin independently of hypertension. Hypertension 1994;23(part 2):823-826.